Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Junctional cadherin complex regulator (JHY) is a protein encoded by the JHY gene, also previously known as C11orf63[1][5][6]. It is predicted to contribute to the assembly of axonemes—the core of motile cilia—in ependymal cells lining the cerebral ventricles[1][4]. Deficiency of JHY in mouse models leads to hydrocephalus, domed cranium, ataxia, weight loss, enlarged ventricles, and neurodegeneration, suggesting its essential role in cerebrospinal fluid circulation and overall brain development[7]. Human mutations are associated with juvenile hydrocephalus[1]. The protein acts upstream of or within biological processes such as motile cilium assembly, planar polarity establishment, and regulation of brain developmental pathways[1][3][6]. There is currently no established evidence for JHY as a direct therapeutic target, nor are there known drugs, clinical biomarkers, or well-characterized mechanisms of pharmacological action targeting this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Junctional cadherin complex regulator (JHY).